aristolochic acid i has been researched along with Hyperuricemia in 2 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wani, SK | 1 |
| Bhat, MDA | 1 |
| Malik, R | 1 |
| Li, YP | 1 |
| Wu, S | 1 |
| Ran, A | 1 |
| Xu, DY | 1 |
| Wei, JM | 1 |
| Zhao, ZL | 1 |
1 trial available for aristolochic acid i and Hyperuricemia
| Article | Year |
|---|---|
Efficacy of Aristolochia rotunda Linn in hyperuricemia: A randomised standard controlled study.
Topics: Aristolochia; Gout; Humans; Hyperuricemia; Single-Blind Method; Uric Acid | 2023 |
1 other study available for aristolochic acid i and Hyperuricemia